StockWatch
·
HomeLiveWeekly

Inmune Bio, Inc.

Ticker: 1711754

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-14.34-4.784.7814.34Q3 FY2022Q1 FY2023Q2 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q1 FY2024Q1 FY2025

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q3 FY2022Q1 FY2023Q2 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q1 FY2024Q1 FY2025
PeriodQ1 FY2025Q1 FY2024Q3 FY2023Q3 FY2023Q2 FY2023Q2 FY2023Q1 FY2023Q3 FY2022
INCOME
Revenue0.05+400.0%0.01-75.0%0.04+0.0%0.04-20.0%0.05+0.0%0.05+25.0%0.04-60.0%0.10
Total Income0.05+400.0%0.01-75.0%0.04+0.0%0.04-20.0%0.05+0.0%0.05+25.0%0.04-60.0%0.10
EXPENSES
Expenditure9.96-9.7%11.03+28.7%8.57+0.0%8.57+32.7%6.46+0.0%6.46+0.0%6.46-14.3%7.54
PROFIT
Net Profit-9.74+11.7%-11.03-28.9%-8.56+0.0%-8.56-31.7%-6.50+0.0%-6.50+0.6%-6.54+15.4%-7.73
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.43+29.5%-0.61-27.1%-0.48+0.0%-0.48-33.3%-0.36+0.0%-0.36+0.0%-0.36+16.3%-0.43

Corporate Events

Board MeetingINMB
2026
16Jun

Board Meeting

Annual Meeting of Stockholders to elect directors, ratify th…

SEC Filing ↗